Table 1 Summary statistics and patients’ characteristics, CD4 and viral load at diagnosis at diagnosis, 2008–2017

Sample

107,018

47,702 (44.58%)

59,313 (55.42%)

 Age

Mean (SD)

33.09 (10.46)

33.50 (10.34)

32.53 (10.50)

 < 0.001

Median (IQR)%

31 (25, 39)

32 (26, 40)

31 (25, 39)

 18–29 yo

43.28

40.04

45.72

 < 0.001

 30–39 yo

32.12

34.38

30.39

 40–49 yo

16.77

17.88

15.94

 50–59 yo

6.03

5.92

6.14

  ≥ 60 yo

1.8

1.79

1.81

Gender (%)

 Male

79.80

77.78

81.4

 < 0.001

 Female

19.79

21.82

18.16

 Transgender

0.41

0.40

0.41

Health facility (%)

 Hospital/ National Institute

20.59

21.12

19.38

 < 0.001

 CAPASITS

66.46

66.32

66.31

Specialized clinics

13.1

12.57

14.31

Region (%)

 Mexico City

16.85

16.68

17.27

 < 0.001

 Central East

30.89

31.60

31.14

 Central West

13.10

13.61

13.18

 Northeast

13.10

13.89

11.84

 Northwest

8.49

8.61

8.39

 South

16.85

15.61

18.17

Marginality Index (%)

 High

2.05

1.85

2.21

 < 0.001

 Medium

1.20

1.13

1.26

 Low

93.61

97.02

96.53

CD4 cells

 Mean (SD)

289 (254)

286 (256)

291 (252)

 < 0.001

 Median (IQR)

233 (88, 417)

226 (88, 410)

238 (89, 422)

 < 0.001

 %

  < 200

44.93

45.58

43.8

 < 0.001

 200–349

22.47

22.44

22.36

 350–499

15.91

14.84

16.01

  ≥ 500

17.79

17.14

17.83

Viral Load (log10)

 Mean (SD)

4.28 (1.39)

4.15 (1.42)

4.38 (1.36)

 < 0.001

 Median (IQR)

4.67 (3.56, 5.27)

4.59 (3.13, 5.19)

4.73 (3.80, 5.32)

 %

 ≤ 100,000 u/ml

62.72

64.76

61.35

 < 0.001

 > 100,000 u/ml

37.44

35.24

38.65